MARKET

PRAH

PRAH

PRA Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

95.41
-0.25
-0.26%
Closed 16:13 07/08 EDT
OPEN
96.06
PREV CLOSE
95.66
HIGH
96.48
LOW
94.18
VOLUME
175.02K
TURNOVER
--
52 WEEK HIGH
113.32
52 WEEK LOW
58.67
MARKET CAP
6.08B
P/E (TTM)
26.02
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PRAH stock price target is 103.15 with a high estimate of 120.00 and a low estimate of 90.00.

EPS

PRAH News

More
PRA Health Sciences to Report Second Quarter 2020 Earnings
GlobeNewswire · 6d ago
PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology
GlobeNewswire · 06/18 13:05
PRA Health Boosts Health Harmony COVID-19 Monitoring Program
Zacks · 06/15 14:24
PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service
GlobeNewswire · 06/12 13:05
Is PRA Health Sciences Inc (PRAH) A Good Stock To Buy?
In this article we will check out the progression of hedge fund sentiment towards PRA Health Sciences Inc (NASDAQ:PRAH) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a c
Insider Monkey · 06/08 06:40
Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign
Investor's Business Daily · 06/04 15:00
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
Seeking Alpha - Article · 06/01 10:28
Why Is PRA Health Sciences (PRAH) Up 7.3% Since Last Earnings Report?
Zacks · 05/30 16:31

Industry

Biotechnology & Medical Research
+1.13%
Pharmaceuticals & Medical Research
+0.50%

Hot Stocks

Symbol
Price
%Change

About PRAH

PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.
More

Webull offers kinds of PRA Health Sciences Inc stock information, including NASDAQ:PRAH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRAH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRAH stock methods without spending real money on the virtual paper trading platform.